CHICAGO EQUITY PARTNERS LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 165 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$2,649,000
-52.3%
262,577
-37.1%
0.27%
-16.3%
Q4 2019$5,556,000
+68.5%
417,407
+8.7%
0.32%
+103.2%
Q3 2019$3,298,000
-21.8%
384,155
-0.4%
0.16%
-16.5%
Q2 2019$4,218,000
-19.7%
385,600
-0.7%
0.19%
-7.4%
Q1 2019$5,256,000
+79.9%
388,435
+37.8%
0.20%
+72.0%
Q4 2018$2,921,000
-45.7%
281,910
-3.2%
0.12%
-25.3%
Q3 2018$5,375,000
+15.1%
291,165
+19.2%
0.16%
+10.5%
Q2 2018$4,671,000
+37.1%
244,275
+10.7%
0.14%
+31.2%
Q1 2018$3,406,000
+6.3%
220,750
+3.3%
0.11%
+11.2%
Q4 2017$3,203,000
+71.9%
213,680
+80.9%
0.10%
+66.1%
Q3 2017$1,863,000
-34.6%
118,135
-21.7%
0.06%
-23.4%
Q2 2017$2,848,000
+36.1%
150,830
+23.0%
0.08%
+28.3%
Q1 2017$2,092,000
-0.2%
122,640
-10.5%
0.06%
+7.1%
Q4 2016$2,096,000
+52.9%
137,100
+58.8%
0.06%
+47.4%
Q3 2016$1,371,00086,3100.04%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$172,422,80022.05%
13D Management LLC 533,562$5,613,0732.85%
Quantedge Capital Pte Ltd 541,200$5,693,4242.22%
Price Jennifer C. 520,000$5,470,4001.74%
Tamarack Advisers, LP 210,000$2,209,2000.81%
Intrinsic Value Partners, LLC 51,605$542,8850.73%
Brown Capital Management 3,933,933$41,384,9750.62%
Old West Investment Management, LLC 75,219$791,3030.43%
EMC Capital Management 43,315$4560.38%
Hillsdale Investment Management Inc. 420,617$4,424,8910.38%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders